Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Chang Hsueh

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biomedicines|October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain InjuryShih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
ACS Pharmacology & Translational Science|April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS ChallengeShih Chang Hsueh, Weiming Luo, David Tweedie, et al.
International Journal of Molecular Sciences|April 12, 2018
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian RatsYu-Wen Yu, Shih-Chang Hsueh, Jing-Huei Lai, et al.
Journal of Biomedical Science|March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injuryDaniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
Geroscience|March 17, 2025
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the ratKai-Yun Chen, Shih-Chang Hsueh, Pathik Parekh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 2, 2022
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesisDaniela Lecca, Yoo Jin Jung, Michael T Scerba, et al.
Journal of Biomedical Science|June 16, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegenerationShih Chang Hsueh, Pathik Parekh, Buyandelger Batsaikhan, et al.
Pharmaceutics|May 28, 2022
3,6'- and 1,6'-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt InflammationYan-Rou Tsai, Dong Seok Kim, Shih-Chang Hsueh, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biomedicines|October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain InjuryShih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
ACS Pharmacology & Translational Science|April 16, 2021
<i>N</i>-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS ChallengeShih Chang Hsueh, Weiming Luo, David Tweedie, et al.
International Journal of Molecular Sciences|April 12, 2018
Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian RatsYu-Wen Yu, Shih-Chang Hsueh, Jing-Huei Lai, et al.
Journal of Biomedical Science|March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injuryDaniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
Geroscience|March 17, 2025
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the ratKai-Yun Chen, Shih-Chang Hsueh, Pathik Parekh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 2, 2022
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesisDaniela Lecca, Yoo Jin Jung, Michael T Scerba, et al.
Journal of Biomedical Science|June 16, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegenerationShih Chang Hsueh, Pathik Parekh, Buyandelger Batsaikhan, et al.
Pharmaceutics|May 28, 2022
3,6'- and 1,6'-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt InflammationYan-Rou Tsai, Dong Seok Kim, Shih-Chang Hsueh, et al.
Pageof 2